Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RF Lean Drop
- Development stage
- Unknown
- Lead developer
- DEMECAN
- Administration
- Inhalation
01
Overview
RF Lean Drop (also known as Demecan RF Lean Drop 22/1 Gastro Pop) is an Indica-dominant hybrid medical cannabis flower product imported and distributed in Germany by DEMECAN. Cultivated in Canada by Rocket Factory, it is derived from the Gastro Pop strain, which is a genetic cross between Apples & Bananas and Grape Gas. The product features a tetrahydrocannabinol (THC) content of approximately 22.0% and a cannabidiol (CBD) content of 1.0% or less. It is prescribed for patients suffering from chronic pain, anxiety, stress, depression, and appetite loss, and is characterized by a terpene profile rich in beta-myrcen, trans-caryophyllene, and ocimen.
- Brand names
- Demecan RF Lean Drop 22/1Demecan RF Lean Drop 22:01
- Other names
- Demecan RF Lean Drop 22/1 Gastro PopGastro Pop
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on RF Lean Drop.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RF Lean Drop.